Helmholtz_HIPS

159 Followers
86 Following
37 Posts
Helmholtz-Institute for Pharmaceutical Research Saarland in Saarbrücken/Germany. #naturalproducts #drugdiscovery #chemistry
Website:https://www.helmholtz-hips.de
Email:[email protected]
Twitter:https://twitter.com/helmholtz_hips
Citizenscience:http://www.microbelix.de
Letzte Woche fand das HIPS Symposium statt, die jährliche wissenschaftliche Konferenz des HIPS am Standort #Saarbrücken. Das Team des Mikrobielle Schatzkiste Projekts war mit dabei und hat #Citizenscience Ergebnisse als Poster präsentiert :) #Saarland https://hips.saarland/sample
Citizenscience - Projekt MICROBELIX - Die Mikrobielle Schatzkiste

Projekt MICROBELIX - Bodenbakterien, die mikrobielle Schatzkiste: eine Mitmach-Aktion zum Bodenproben sammeln des Helmholtz Instituts für Pharmazeutische Forschung Saarland (HIPS), Saarbrücken.

Das HIPS bildet aus! Drei Ausbildungsplätze zur Chemielaborant*in und Biologielaborant*in sind aktuell ausgeschrieben, Start zum 1. September. https://hips.saarland/ausbildung
Biologielaborantin Chemielaborantin Ausbildungsplatz - Helmholtz Institut für Pharmazeutische Forschung Saarland

Ausbildung Biologielaborant/in oder Chemielaborant/in am Helmholtz Institut für Pharmazeutische Forschung (HIPS), Saarland, Saarbrücken

ERC Proof of Concept Grant for Anna Hirsch! The HIPS scientist receives funding to develop new antibiotics. | Press release https://www.helmholtz-hips.de/en/news-events/news/detail/news/erc-proof-of-concept-grant-for-anna-hirsch/
ERC Proof of Concept Grant for Anna Hirsch

Prof Anna Hirsch has succeeded in acquiring a coveted ERC grant for the second time. Under the "Proof of Concept" funding program, she will receive €150,000 to bring her basic research findings closer to a potential application.

Helmholtz Institute for Pharmaceutical Research Saarland
Disarming pathogens - bacterial communication as a target for new drugs. | Towards Translation of PqsR Inverse Agonists: From In Vitro Efficacy Optimization to In Vivo Proof-of-Principle https://doi.org/10.1002/advs.202204443
The team of Alexander Titz at HIPS and collaborators developed novel pathoblockers acting on Lectins to fight infections with Pseudomonas aeruginosa. Read more on our website (English and German version available). https://www.helmholtz-hips.de/en/news-events/news/detail/news/sugar-based-inhibitors-disarm-the-pathogen-pseudomonas-aeruginosa/
📢 Registration is open for our yearly 1-day conference on pharmaceutical sciences devoted to infection research! Check out the list of speakers and join the #HIPS2023 symposium on-site in Saarbrücken/Germany or as a remote participant. https://hips.saarland/symposium
HIPS Symposium 2023 - Helmholtz Institute for Pharmaceutical Research Saarland

HIPS Symposium 2023, Helmholtz Institute for Pharmaceutical Research Saarland, Saarbrücken

Our study on the myxobacterial antibiotic Myxovalargin including biosynthesis, structural revision, total synthesis, and molecular characterization of ribosomal inhibition now online in JACS. https://pubs.acs.org/doi/10.1021/jacs.2c08816
📢 Registration is now open for our yearly 1-day conference on pharmaceutical sciences devoted to infection research! Join the #HIPS2023 symposium on-site in Saarbrücken/Germany or as a remote participant. More speakers to be announced soon. https://hips.saarland/symposium
HIPS Symposium 2023 - Helmholtz Institute for Pharmaceutical Research Saarland

HIPS Symposium 2023, Helmholtz Institute for Pharmaceutical Research Saarland, Saarbrücken

Our chemists are also concerned with improvement of #naturalproducts scaffolds using (semi)synthesis: Regio- and Stereoselective Epoxidation and Acidic Epoxide Opening of Antibacterial and Antiplasmodial Chlorotonils Yield Highly Potent Derivatives.
https://doi.org/10.1002/anie.202202816
We are mainly searching for new anti-infective #naturalproducts but we won't look away when we find molecules from #myxobacteria with other striking properties, like in this article - Expanding the Ajudazol Cytotoxin Scaffold: Insights from Genome Mining, Biosynthetic Investigations, and Novel Derivatives. https://doi.org/10.1021/acs.jnatprod.2c00637